Titan Pharmaceuticals, Inc. announced that it has executed a specialty product distribution agreement with CVS Caremark, a subsidiary of CVS Health, further expanding access to treatment with Probuphine implant, Titan’s novel maintenance treatment for Opioid Use Disorder in eligible patients.
July 9, 2019
· 9 min read